Editorial: Tumor microenvironment and hematological malignancies: new evidences and new questions

Stefania Fiorcari; Paolo Strati; Elisabetta Dondi

doi:10.3389/fimmu.2024.1407981

Editorial: Tumor microenvironment and hematological malignancies: new evidences and new questions

Front Immunol. 2024 Apr 16:15:1407981. doi: 10.3389/fimmu.2024.1407981. eCollection 2024.

Authors

Stefania Fiorcari¹, Paolo Strati², Elisabetta Dondi³

Affiliations

¹ Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.
² Department of Lymphoma and Myeloma & Department of Translational Molecular Pathology The University of Texas MD (UT MD) Anderson Cancer Center, Houston, TX, United States.
³ U978 Institut National de la Santé et de la Recherche Médicale/Université Sorbonne Paris Nord, Labex INFLAMEX, Bobigny, France.

No abstract available

Keywords: hematological malignancies; homeostasis; immune escape; niches; signaling; tumor microenvironment.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Hematologic Neoplasms* / etiology
Hematologic Neoplasms* / immunology
Humans
Tumor Microenvironment* / immunology

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. SF is supported by Ricerca Finalizzata Giovani Ricercatori GR-2021-12372864; PS is supported by Sobi, Astrazeneca Acerta, ALX Oncology, ADC Therapeutics, Kite Gilead; Leukemia Lymphoma Society, Kite-Gilead, Sabin Family; ED is supported by Labex INFLAMEX, contract ANR11 IDEX00502 and by the TRANSCAN H2020 Fire CLL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.